Turkish Journal of Medical Sciences
Author ORCID Identifier
YÜKSEL ÇAVUŞOĞLU: 0000-0002-4027-9873
SELDA MURAT: 0000-0002-3935-0222
ANIL ŞAHİN: 0000-0003-3416-5965
İNCİ TUĞÇE ÇÖLLÜOĞLU: 0000-0002-2227-6177
DİLEK URAL: 0000-0003-0224-1433
MEHMET YILMAZ: 0000-0002-8169-8628
SANEM NALBANTGİL: 0000-0002-9798-9796
NAİM ATA: 0000-0001-6947-2821
MUSTAFA ÜLGÜ: 0000-0003-0825-1851
ŞUAYİP BİRİNCİ: 0000-0001-8104-6198
EMRE DEMİR: 0000-0001-7552-8967
EMİNE KANIK: 0000-0002-7068-1599
DOI
10.55730/1300-0144.5934
Abstract
Background/aim: Heart Failure (HF) is associated with a wide range of comorbidities that negatively impact on clinical outcomes and cause to high economic burden. We aimed to evaluate frequency and burden of comorbidities in HF patients in Türkiye and their relationship with the patient's demographic characteristics.Materials and methods: Based on ICD-10 codes in National Electronic Database of the Turkish Ministry of Health, covering the entire population of Türkiye (n=85,279,553), from January 1, 2016, to December 31, 2022, prevalence of comorbidities in HF patients were obtained. Frequency and burden of comorbidities were analyzed separately by age groups, gender and socioeconomic status (SES).Results: Between 2016 and 2022, there were 2,722,151 patients (51.7% female) of all ages who were diagnosed with HF. In Türkiye, the most common comorbidities in HF patients were hypertension (HT) (97.6%), atherosclerotic cardiovascular disease (ASCVD) (84.9%), dyslipidemia (59.5%), anxiety disorder (48.1%), diabetes mellitus (DM) (45.2%), chronic obstructive pulmonary disease (COPD) (43.6%), anemia (40.6%), and atrial fibrillation (AF) (37.1%). Females had a higher rate of anemia, DM, HT and anxiety disorders, while males had a higher rate of ASCVD, COPD, and dyslipidemia. The most common comorbidity in patients under 20 years of age was congenital heart disease (52.3%). More than 90% of HF patients have had ≥2 comorbidities. HF patients with ≥5 comorbidities increased from 18.1% in the group with 20-49 years of age to 38.3% in the group with 50-79 years of age. Comorbidities were similar across the SES groups.Conclusion: The most common comorbidities in HF in Türkiye are HT, ASCVD, dyslipidemia, DM, COPD, anemia and AF, respectively, and more than 90% of patients have ≥2 comorbidities. While ASCVD and dyslipidemia were more common in men; anemia, DM and anxiety disorders were more common in women. The number of comorbid conditions increases with advanced age.
Keywords
Comorbidity, comorbidity burden, electronic health records, heart failure
First Page
1478
Last Page
1487
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
ÇAVUŞOĞLU, YÜKSEL; MURAT, SELDA; ŞAHİN, ANIL; ÇÖLLÜOĞLU, İNCİ TUĞÇE; URAL, DİLEK; YILMAZ, MEHMET BİRHAN; NALBANTGİL, SANEM; ATA, NAİM; ÜLGÜ, MUSTAFA MAHİR; BİRİNCİ, ŞUAYİP; DEMİR, EMRE; KANIK, EMİNE ARZU; ASARCIKLI, LALE DİNÇ; and ÇELİK, AHMET
(2024)
"Burden of comorbidities in heart failure patients in Türkiye,"
Turkish Journal of Medical Sciences: Vol. 54:
No.
7, Article 9.
https://doi.org/10.55730/1300-0144.5934
Available at:
https://journals.tubitak.gov.tr/medical/vol54/iss7/9